Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies

Mycobacteria cause a variety of diseases, such as tuberculosis, leprosy, and opportunistic diseases in immunocompromised people. The treatment of these diseases is problematic, necessitating the development of novel treatment strategies. Recently, β-carbonic anhydrases (β-CAs) have emerged as potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Aspatwar, Ashok, Winum, Jean-Yves, Carta, Fabrizio, Supuran, Claudiu T., Hammaren, Milka, Parikka, Mataleena, Parkkila, Seppo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278287/
https://www.ncbi.nlm.nih.gov/pubmed/30413024
http://dx.doi.org/10.3390/molecules23112911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278287/
https://www.ncbi.nlm.nih.gov/pubmed/30413024
http://dx.doi.org/10.3390/molecules23112911

Ejemplares similares